Amryt Pharma plc (AMYT) Discounted Future Market Cap - Discounting Cash Flows
Amryt Pharma plc
AMYT (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 75.12 Thou. USD
Estimated net income -146.1 Bil. USD
Estimated market capitalization 6,930 Bil. USD
Market capitalization discounted to present 4,811 Bil. USD
Shares Outstanding 64.05 Mil.
Earnings Per Share (EPS) -0.31 USD
Market Price 14.7 USD
Price to Earnings (PE) Ratio -38.16

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue
243.6 339.1 1,339 5,289 20,885 82,475
Revenue Growth Rate
294.9% 294.9% 294.9% 294.9%
Net Income
-19.96 -600.9 -2,373 -9,372 -37,008 -146,146

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 105.7 243.6
222.5 182.6 58.12 16.53 15.33 1.42 0
Cost of Revenue 58.19 127
106.1 119 42 6.06 6.45 0.616 0
Gross Profit 47.55 116.6
116.4 63.58 16.12 10.47 8.88 0.805 0
Gross Margin 48.67% 47.86%
52.32% 34.82% 27.74% 63.35% 57.95% 56.62%
Operating Income -28.84 -45.08
-21.64 -45.44 -36.04 -17.45 -17.04 -8.08 -39.93
Operating Margin -128.6% -18.5%
-9.72% -24.89% -62.01% -105.5% -111.2% -568.6%
Net Income -41.41 -19.96
-18.17 -104.5 -65.53 -29.49 -45.67 -8.21 -39.74
Net Margin -177.2% -8.19%
-8.16% -57.24% -112.8% -178.3% -297.9% -577.6%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 105.7 243.6
222.5 182.6 58.12 16.53 15.33 1.42 0
Revenue Growth Rate 294.8%
21.87% 214.2% 251.5% 7.85% 978.8%
Net Income -41.41 -19.96
-18.17 -104.5 -65.53 -29.49 -45.67 -8.21 -39.74
Net Margin -177.2% -8.19%
-8.16% -57.24% -112.8% -178.3% -297.9% -577.6%
Net Income Growth Rate 270.7%
-82.62% 59.5% 122.3% -35.43% 456.4% -79.35% 1,454%
Stockholders Equity 86.67 0
337.4 66.14 129.3 -3.7 26.26 34.75 16.47
Equity Growth Rate -476.5%
410.2% -48.85% -3,599% -114.1% -24.43% 111% -70.56%
Return on Invested Capital (ROIC) 5,002%
-2.57% -14.16% -9.59% -30.36% -41.57% -17.75% 35,130%
After-tax Operating Income -36.97 -36.56
-13.19 -44.87 -35.38 -17.47 -24.82 -9.98 -113.5
Income Tax Rate -24.05% 18.89%
39.05% 1.26% 1.84% -0.14% -45.64% -23.55% -184.1%
Invested Capital 196 0
513.3 316.8 368.9 57.55 59.72 56.23 -0.323
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us